112 publications
Name | Date | Type | Actions |
---|---|---|---|
Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health. |
08/02/2021 | press release excluding results | |
Financial report 2007 Consolidated 2007 figures are even better than the targets in the business plan we presented for the initial public offering (IPO) in November 2006. |
15/05/2008 | Reference document | |
2008 financial report Laboratoire pharmaceutique vétérinaire familial et indépendant, Vétoquinol se consacre exclusivement à la santé animale. Son activité est volontairement équilibrée entre animaux de rente et animaux de compagnie. |
04/05/2009 | Reference document | |
Reference Document 2009 Reference Document 2009 |
23/04/2010 | Reference document | |
Reference Document 2012 (in french) Reference Document 2012 (in french) |
16/04/2013 | Reference document | |
Reference Document 2013 Reference Document 2013 |
14/04/2014 | Reference document | |
Registration Document 2014 Registration Document 2014 |
20/04/2015 | Reference document | |
Document d’enregistrement universel (URD) 2022 version XBRL Document d'enregistrement universel 2022 incluant le rapport financier annuel |
13/04/2023 | Reference document | |
2019 Universal registration document Note to recipient of this document: this is the translation of an extract of the Universal Registration Document and Annual Financial Report for the year ended December 31, 2019. The original French document was filed with the AMF (French Financial Markets Authority) on April 23, 2020.
|
23/04/2020 | Reference document | |
2017 Registration document 2017 Registration document |
23/04/2018 | Reference document |